Literature DB >> 4042222

Synthesis and structure-activity study of protease inhibitors. IV. Amidinonaphthols and related acyl derivatives.

T Aoyama, T Okutome, T Nakayama, T Yaegashi, R Matsui, S Nunomura, M Kurumi, Y Sakurai, S Fujii.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4042222     DOI： 10.1248/cpb.33.1458

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  4 in total

1.  Mechanisms of the hyperkalaemia caused by nafamostat mesilate: effects of its two metabolites on Na+ and K+ transport properties in the rabbit cortical collecting duct.

Authors:  S Muto; M Imai; Y Asano
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

2.  Synthesis and Cytotoxicity of N-Substituted Dibenzo[a,j]xanthene-3,11-dicarboxamide Derivatives.

Authors:  Yongbin Song; Yihui Yang; Lijun Wu; Naiwei Dong; Shang Gao; Hongrui Ji; Xia Du; Bo Liu; Guoyou Chen
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

3.  Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19.

Authors:  Yong-Soon Cho; Jae-Gook Shin
Journal:  Transl Clin Pharmacol       Date:  2022-03-09

4.  Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis.

Authors:  Hyeon Seok Oh; Taehyung Kim; Dong-Hyeon Gu; Tae Suk Lee; Tae Hwan Kim; Soyoung Shin; Beom Soo Shin
Journal:  Molecules       Date:  2022-03-14       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.